Physician profile
Christopher Ng
NPI 1134127616
$3,555.20
in general payments reported to CMS, 2019-2025
19 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $553 · 2021: $617 · 2022: $660 · 2023: $277 · 2024: $145 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.32 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $994.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $674.33 | 2019-2025 | Farxiga, Breztri |
| Lilly USA, LLC | $286.81 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $253.82 | 2019-2023 | Trelegy Ellipta |
| Kowa Pharmaceuticals America, INC. | $227.03 | 2019-2022 | |
| Pfizer INC. | $213.74 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.95 | 2019-2023 | |
| Abiomed | $129.83 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $124.00 | 2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $86.82 | 2019-2022 | |
| Allergan, INC. | $72.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.68 | 2019-2023 | |
| Amgen INC. | $56.98 | 2019-2020 | |
| Amarin Pharma, INC. | $52.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $42.07 | 2019-2023 | Xarelto |
| Althera Pharmaceuticals LLC | $34.07 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $26.03 | 2025 | Orgovyx |
| Bausch Health US, LLC | $18.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.